Hiroshi Okazaki

3.9k total citations
169 papers, 3.1k citations indexed

About

Hiroshi Okazaki is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Hiroshi Okazaki has authored 169 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Organic Chemistry, 43 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Hiroshi Okazaki's work include Asymmetric Hydrogenation and Catalysis (9 papers), Fungal Biology and Applications (7 papers) and Advancements in Photolithography Techniques (7 papers). Hiroshi Okazaki is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (9 papers), Fungal Biology and Applications (7 papers) and Advancements in Photolithography Techniques (7 papers). Hiroshi Okazaki collaborates with scholars based in Japan, United States and Germany. Hiroshi Okazaki's co-authors include TAKAO NOTO, Yoh Takuwa, Yutaka Yatomi, Hiroyuki Okamoto, Noriko Takuwa, Koichi Gonda, Toshiaki Hayashi, Koji Suzuki, Hideo Oishi and Hiroshi Sasaki and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Hiroshi Okazaki

159 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Okazaki Japan 28 1.3k 562 346 336 306 169 3.1k
Michał Woźniak Poland 30 1.3k 1.0× 462 0.8× 201 0.6× 195 0.6× 232 0.8× 147 3.4k
Kazumi Sasamoto Japan 18 1.3k 1.0× 338 0.6× 248 0.7× 140 0.4× 204 0.7× 49 3.3k
Mark A. Levy United States 33 2.0k 1.5× 449 0.8× 176 0.5× 225 0.7× 644 2.1× 100 3.4k
Vladimirov IuA Russia 31 2.0k 1.5× 562 1.0× 176 0.5× 244 0.7× 92 0.3× 309 4.4k
Mushtaq Ahmad United States 20 1.3k 1.0× 341 0.6× 251 0.7× 124 0.4× 298 1.0× 67 3.3k
Abhijit Ray United States 37 1.8k 1.4× 504 0.9× 208 0.6× 143 0.4× 532 1.7× 116 4.2k
C C Winterbourn New Zealand 24 970 0.7× 306 0.5× 91 0.3× 224 0.7× 331 1.1× 32 2.9k
Vincenzo Zappia Italy 41 2.6k 2.0× 702 1.2× 133 0.4× 237 0.7× 441 1.4× 124 5.3k
A. Samuni Israel 32 1.2k 0.9× 725 1.3× 118 0.3× 141 0.4× 261 0.9× 76 3.6k
Masayuki Arakawa Japan 24 952 0.7× 243 0.4× 349 1.0× 222 0.7× 192 0.6× 78 2.8k

Countries citing papers authored by Hiroshi Okazaki

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Okazaki more than expected).

Fields of papers citing papers by Hiroshi Okazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Okazaki. The network helps show where Hiroshi Okazaki may publish in the future.

Co-authorship network of co-authors of Hiroshi Okazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Okazaki. A scholar is included among the top collaborators of Hiroshi Okazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Okazaki. Hiroshi Okazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokoyama, Akihito, et al.. (2021). Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data. Allergology International. 71(1). 47–54. 8 indexed citations
2.
Kaneko, Takashi, Kazuya Sugimori, Taito Fukushima, et al.. (2019). Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis. Clinical Journal of Gastroenterology. 12(5). 484–489. 2 indexed citations
3.
Hayashida, Tetsu, et al.. (2014). An E2F1-HOXB9 Transcriptional Circuit Is Associated with Breast Cancer Progression. PLoS ONE. 9(8). e105285–e105285. 17 indexed citations
4.
Ono, Yoshihiro, Tetsu Hayashida, Ayano Konagai, et al.. (2011). Direct inhibition of the transforming growth factor‐β pathway by protein‐bound polysaccharide through inactivation of Smad2 signaling. Cancer Science. 103(2). 317–324. 20 indexed citations
5.
Kometani, Takuro, Ichiro Yoshino, Naoko Miura, et al.. (2009). Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway. Cancer Letters. 278(1). 27–33. 49 indexed citations
6.
Okuno, Toshiaki, Yoshiko Iizuka, Hiroshi Okazaki, et al.. (2008). 12(S)-hydroxyheptadeca-5Z, 8E, 10E–trienoic acid is a natural ligand for leukotriene B4 receptor 2. The Journal of Experimental Medicine. 205(4). 759–766. 147 indexed citations
7.
Okazaki, Hiroshi, et al.. (2006). Concentration of Loline Alkaloids in Italian Ryegrass Infected with Neotyphodium uncinatum. 51(4). 390–397. 7 indexed citations
8.
Ramírez, Fausto, et al.. (2002). Improved Preparation of Phosphorylating Reagents Derived From the Acetoin Enediol Cyclophosphoryl Function. Synthesis. 1976(12). 819–821. 1 indexed citations
9.
Ishizaka, Nobukazu, Hiroshi Okazaki, Kiyoshi Kurokawa, Mamoru Kumada, & Yoh Takuwa. (1994). Molecular cloning of a novel putative G protein-coupled receptor from rat aortic smooth muscle. Downregulation of the mRNA level by the cyclic AMP messenger pathway. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1218(2). 173–180. 5 indexed citations
10.
Taguchi, Junichi, et al.. (1993). L-arginine inhibits neointimal formation following balloon injury. Life Sciences. 53(23). PL387–PL392. 38 indexed citations
11.
Okazaki, Hiroshi, et al.. (1992). Barbiturates suppress glucose utilization by inhibition of hexokinase in neuroblastoma cells. Biochemical and Biophysical Research Communications. 184(2). 673–679. 5 indexed citations
12.
Okazaki, Hiroshi, et al.. (1992). Possible Involvement of Cathepsin L in Processing of Rat Liver Hexokinase to Eliminate Mitochondria-Binding Ability. The Journal of Biochemistry. 112(3). 409–413. 2 indexed citations
13.
14.
Ohnaka, Keizo, et al.. (1990). Identification and characterization of endothelin converting activity in cultured bovine endothelial cells. Biochemical and Biophysical Research Communications. 168(3). 1128–1136. 77 indexed citations
15.
16.
Okazaki, Hiroshi, et al.. (1987). Assessment of CO2 reactivity by transcranial Doppler flowmetry. Nosotchu. 9(5). 397–402. 4 indexed citations
17.
Mochida, Isao, et al.. (1987). Selective hydrogenation of acridine by using noble metal catalysts.. NIPPON KAGAKU KAISHI. 1033–1039. 1 indexed citations
18.
Okazaki, Hiroshi. (1972). On Cell Wall Lytic Activity Produced by Thermophilic Actionmycetes : (II) Some Properties of the Crude Enzyme Produced by Micropolyspora sp. No. 434 and Conditions for Its Production. Journal of Fermentation Technology. 50(6). 405–413. 1 indexed citations
19.
Hirao, Ichiro, Tsutomu Fujimoto, Yasuhiko Kato, & Hiroshi Okazaki. (1963). Synthesis of 5-Nitro-2-furfurylidenehydrazinopyrimidines. The Journal of the Society of Chemical Industry Japan. 66(11). 1682–1685. 1 indexed citations
20.
SAKAGUCHI, Kinichirô, et al.. (1955). A Note on the Comparison of Kôji and Submerged Cultures. Nippon Nōgeikagaku Kaishi. 29(5). 349–353. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michał Woźniak Breakdown of academic impact, for papers by Kazumi Sasamoto Breakdown of academic impact, for papers by Mark A. Levy Breakdown of academic impact, for papers by Vladimirov IuA Breakdown of academic impact, for papers by Mushtaq Ahmad Breakdown of academic impact, for papers by Abhijit Ray Breakdown of academic impact, for papers by C C Winterbourn Breakdown of academic impact, for papers by Vincenzo Zappia Breakdown of academic impact, for papers by A. Samuni Breakdown of academic impact, for papers by Masayuki Arakawa
Rankless by CCL
2026